Background
Group One, Ltd. owned U.S. Patent Nos. 5,518,492 and 5,711,752, both directed to a machine for producing curled and shredded ribbon used in decorative packaging. Group One alleged that Hallmark Cards, Inc. infringed these patents. Hallmark counterclaimed that the patents were invalid under the on-sale bar of 35 U.S.C. § 102(b), which provides that a patent is invalid if the claimed invention was “on sale” more than one year before the patent application was filed.
The district court found that certain communications between Group One and a third party more than one year before the critical date constituted an invalidating “offer for sale.” Group One appealed, arguing the communications were merely preliminary negotiations — not a true commercial offer — and that no sale was ever consummated.
The central question was what legal standard courts should use to determine whether a communication constitutes a commercial “offer for sale” under § 102(b), a question the Federal Circuit had not yet definitively resolved in the wake of the Supreme Court’s 1998 decision in Pfaff v. Wells Electronics.
The Court’s Holding
The Federal Circuit reversed the finding of invalidity. Writing for the court, Judge Michel held that whether a communication rises to the level of a commercial offer for sale must be determined under Federal Circuit law, not regional circuit or state law. Guided by the Supreme Court’s Pfaff decision, which required an actual commercial offer for sale, the Federal Circuit held that courts should look to the Uniform Commercial Code to define what constitutes such an offer.
Under the UCC, an offer requires a manifestation of willingness to enter into a bargain, framed in sufficiently definite terms, such that acceptance would conclude a contract. Preliminary negotiations, demonstrations, or expressions of interest — even if accompanied by pricing information — do not necessarily constitute an offer capable of acceptance. The court emphasized that not every business communication about a product triggers the bar; the communication must be a genuine offer that, if accepted, would bind the offeror to a contract of sale.
Applying this standard, the court found that Group One’s communications with the potential buyer did not rise to the level of an offer under the UCC because the parties had not yet reached agreement on material terms. No invalidating offer had been made within the critical period.
Key Takeaways
- The on-sale bar of § 102(b) requires a “commercial offer for sale” — a genuine offer under UCC contract principles, not merely preliminary negotiations or demonstrations.
- Whether a communication constitutes a commercial offer is a question of Federal Circuit law, not state law or regional circuit law.
- Courts must assess whether the communication, if accepted, would have created a binding contract for sale of the invention.
- Inventors who demonstrate their products to potential customers, discuss pricing, or enter negotiations do not automatically trigger the bar without a true UCC-qualifying offer.
- This case operationalized the Supreme Court’s Pfaff decision by supplying the UCC framework for determining what counts as an “offer for sale.”
Why It Matters
The on-sale bar is one of the most litigated triggers of patent invalidity. Before Group One, courts struggled to define exactly when business communications crossed the line from negotiation to an invalidating offer. By anchoring the analysis in the UCC’s definition of a commercial offer, Group One gave patent owners and accused infringers a workable framework: the same principles that govern commercial contract formation determine whether the bar applies.
The decision protects inventors who reasonably explore the commercial viability of their inventions — through demonstrations, preliminary discussions, and proposals — without inadvertently triggering the bar. At the same time, it ensures that inventors who make firm offers of sale cannot extend their monopoly by delaying patent filings. Group One remains a foundational authority on the on-sale bar and is regularly cited in pharmaceutical, industrial, and consumer products patent litigation.